Pangea Biomed

Indonesia
Kador, Riau, Indonesia

Company profile

Pangea Biomed company profile

Pangea Biomed combines ML and RNA sequencing to offer personalized cancer treatment. The company's ENLIGHT platform can surface relevant biological insights to pinpoint the best path forward in combating a patient's cancer by combining the hidden power of RNA sequencing with ML-enabled network effects. It examines the molecular context in which targeted therapies operate, looking beyond actionable genomic abnormalities. Pangea's goal is to democratize precision oncology, bringing deep tumor intelligence to drug development and to treatment nomination for patients.

Business identity

Phone number
03-5441755
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$12M
Last funding
Seed / $5M / 2022-12-15
Last equity funding
Seed / $5M
Investors
2
Lead investors
2
Articles
9

Founders and investors

Lead investors

Danny TocatlyNFX

Investors

Danny TocatlyNFX